Onward Therapeutics Announces Enrollment Of Phase 1 Clinical Trial Of A Novel Bispecific Antibody (OT-A201) ...

(MENAFN - PR Newswire) EPALINGES,Switzerland and PARIS, Jan. 24, 2024 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics), a global biotechnology company focused on developing innovative ... ...

Related Keywords

Epalinges ,Switzerland General ,Switzerland ,Paris ,France General ,France , ,Onward Therapeutics ,Com Finance Health Marketing Menafn Pharmaceuticals ,